Effective (Delivering Evidence-Based & High-Quality Care)
Clinical Effectiveness Policy
Clinical Effectiveness Policy
HAUS OF ÄSTHETIK
Effective (Delivering Evidence-Based & High-Quality Care)
1. Purpose
HAUS OF ÄSTHETIK is committed to ensuring that all treatments provided are evidence-based, effective, and aligned with best practice guidelines. This policy establishes a framework to ensure that clinical interventions meet the highest standards of care, as outlined by NICE, CQC, Save Face, and other regulatory bodies. It also ensures that staff maintain ongoing competence and compliance with clinical governance requirements.
This policy aligns with:
• National Institute for Health and Care Excellence (NICE) Guidelines
• Care Quality Commission (CQC) Regulation 12 – Safe Care & Treatment
• Save Face Standards for Clinical Governance & Evidence-Based Practice
• Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
• General Medical Council (GMC) & Nursing & Midwifery Council (NMC) CPD & Revalidation Requirements
• UK Resuscitation Council Best Practice Guidelines
• British Association of Cosmetic Nurses (BACN) & Joint Council for Cosmetic Practitioners (JCCP) Standards
This policy ensures that all treatments, interventions, and procedures are clinically effective and continuously improved through ongoing professional development (CPD) and quality assurance.
2. Scope
This policy applies to:
• All clinical staff performing aesthetic treatments.
• Agency, temporary, and subcontracted personnel providing clinical services.
• Senior Leadership Team responsible for clinical governance and effectiveness.
• All patients receiving treatments at HAUS OF ÄSTHETIK.
3. Legal & Regulatory Requirements
3.1 NICE Guidelines & Evidence-Based Practice
HAUS OF ÄSTHETIK ensures that:
• All treatments are aligned with current NICE guidelines and other relevant best practice frameworks.
• Only evidence-based techniques and protocols are used to ensure patient safety and treatment efficacy.
• Practitioners must regularly review updated NICE and clinical guidance to inform practice and update treatment protocols accordingly.
3.2 CQC Regulation 12 – Safe Care & Treatment
Under this regulation, HAUS OF ÄSTHETIK must:
• Ensure all treatments provided are safe and meet professional standards.
• Conduct risk assessments before any procedure.
• Ensure staff have the training, qualifications, and competence to deliver evidence-based treatments.
• Demonstrate accountability and adherence to clinical governance frameworks.
4. Delivering Evidence-Based Treatments
4.1 Treatment Protocols & Best Practice
• All procedures will be carried out using standardised clinical protocols to ensure consistency, efficacy, and patient safety.
• Protocols will be reviewed quarterly to reflect the latest best practice recommendations and evolving industry standards.
• Only UK-approved medical devices, injectables, and pharmaceutical-grade products will be used.
• Where new treatments are introduced, a full risk-benefit analysis must be completed before implementation.
4.2 Ongoing Monitoring of Clinical Effectiveness
• Outcomes of treatments will be monitored through structured patient follow-ups, feedback, and clinical audits.
• Complication rates, adverse reactions, and patient-reported outcome measures (PROMs) will be reviewed regularly.
• Clinical effectiveness data will be assessed in monthly governance meetings and used to inform policy updates.
4.3 Professional Development & CPD Compliance
• All clinical staff must engage in continuous professional development (CPD) and demonstrate competence in new and emerging techniques.
• CPD activities must include training on the latest safety protocols, innovations, and NICE guidelines.
• Practitioners are responsible for maintaining professional registration and completing revalidation requirements (NMC, GMC, BACN, or equivalent bodies).
• Quarterly clinical training sessions will be held to review and reinforce treatment protocols and best practices.
5. Clinical Audit & Quality Improvement
5.1 Audit Process
• Annual clinical audits will be conducted to assess treatment effectiveness, patient safety, and adherence to best practice protocols.
• Audit findings will be used to identify areas for improvement and inform continuous quality improvement initiatives.
• Key performance indicators (KPIs) will be established to monitor treatment success rates and patient satisfaction.
5.2 Learning from Patient Feedback
• Structured patient satisfaction surveys will be conducted post-treatment.
• Negative feedback, complications, or concerns will be investigated, and corrective measures will be implemented where necessary.
• A ‘feedback-to-action’ approach will ensure that lessons learned from audits and patient input lead to tangible service improvements.
6. Risk Management & Clinical Governance
• A risk assessment must be completed for all new treatments before implementation.
• New procedures must undergo a pilot phase under controlled conditions before being introduced to all patients.
• An appointed Clinical Governance Lead will oversee all quality improvement measures, monitor patient outcomes, and ensure regulatory compliance.
• Incident reporting and Root Cause Analysis (RCA) will be mandatory for all significant complications or deviations from standard procedures.
7. Staff Training & Compliance Monitoring
• Annual Clinical Effectiveness Training is mandatory for all practitioners, ensuring up-to-date knowledge and compliance with industry standards.
• Quarterly reviews of treatment protocols and audits will be conducted to identify trends and areas for improvement.
• Action plans for continuous improvement will be implemented based on audit findings and regulatory updates.
• External CPD courses and peer-learning opportunities will be encouraged to promote a high standard of professional practice.
8. Review & Continuous Improvement
• This policy will be reviewed annually or following significant clinical developments, industry changes, or regulatory updates.
• Compliance with CQC, Save Face, NICE, and CPD standards will be continuously monitored through governance meetings.
• New evidence-based techniques will be incorporated into practice as they become available.
• A ‘culture of learning’ will be embedded within the organisation to ensure continuous quality improvement and best practice adaptation.
9. Conclusion
• HAUS OF ÄSTHETIK is committed to delivering the highest standards of clinical effectiveness through evidence-based treatments, ongoing staff training, and continuous quality improvement. By aligning with CQC, NICE, Save Face, and professional regulatory bodies, we ensure that patients receive the safest, most effective aesthetic treatments available.
• This policy reinforces our commitment to clinical excellence, professional integrity, and best practice standards, ensuring optimal patient outcomes and a culture of continuous improvement in aesthetic medicine.